logo
Skip to content
  • About Us
    • Our Mission
    • Our Culture
    • Our People
      • Founders
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
    • Investors
  • Research & Technology
    • Our Science
    • Strategy
    • Scientific Papers
    • Partnering
  • News & Events
  • Contact Us
header image

News & Events

News & Events

05/13/2013
Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases

SAN DIEGO, May 02, 2013 — Abide Therapeutics, a biopharmaceutical company… read more

12/14/2012
Abide and ActivX Complete Technology Agreement:

We are pleased to announce that Abide Therapeutics, Inc., San Diego… read more

09/24/2012
Backing Biotech Innovation
San Diego Business Journal
03/30/2012
Abide Therapeutics and SCYNEXIS, Inc. Collaborate In Finding Novel Anti-Viral and Anti-Parasitic Agents
Market Watch, The Wall Street Journal

RESEARCH TRIANGLE PARK, N.C. – SCYNEXIS, Inc. announced today that it… read more

02/13/2012
Abide: Selecting Serine Hydrolases
BioCentury

BioCentury February 13, 2012 By Joanne Kotz Senior Editor Abide Therapeutics… read more

11/17/2011
Dampening Neuroinflammation
SciBX

A California team has shown that monoacylglycerol lipase, which controls levels… read more

© 2012 Abide Therapeutics Inc. All Rights Reserved
  • Home
  • Legal
  • Contact